Tag: Biocon Biologics

Advancing Bone Health: European Commission Approves Biocon Biologics’ Denosumab Biosimilars

BENGALURU, India, July 3, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsBiocon Biologics

Binance Exchange Launches bStocks Tokenized Securities: 1:1 Backing and 24/7 Trading

Shapermint Pairs DTC Reach with Cultural Relevance in Two-Part Extra TV Partnership

Nieuwe peiling: 82% van de Nederlanders benadrukt hun ‘fundamentele recht’ om gehoord te worden in openbare consultaties

Tag: Biocon Biologics

Advancing Bone Health: European Commission Approves Biocon Biologics’ Denosumab Biosimilars

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us